Recombinant
RabMAb

Anti-Cytokeratin 5 antibody [SP27], prediluted (ab64080)

Publishing research using ab64080? Please let us know so that we can cite the reference in this datasheet.

ab64080 has been referenced in 1 publication.

  • Kalinsky K  et al. Proteomic modulation in breast tumors after metformin exposure: results from a "window of opportunity" trial. Clin Transl Oncol 19:180-188 (2017). PubMed: 27305912

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up